Polyclonal antibodies are produced when different B-cell clones in the immune system respond to the same antigen. It produces a variety of antibodies that can bind to different sites on that antigen.
Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
Antibodies are a major component of adaptive immunity against invading pathogens. In this presentation, we will describe an analytical approach to characterize the antigen-specific antibody repertoire ...
A new deal between CSL and Memo Therapeutics centers on Memo's Dropzylla discovery platform, an antibody repertoire copying engine based on microfluidic single-cell processing of human B cells.
Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb ® antibody discovery platform was used to sequence a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results